A recent study aggregated RNA sequencing data from more than 3000 samples to create a user-friendly database of transcription profiles in leukemia and related cell lines. The origin and ...
Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present in many patients with Acute Myeloid Leukemia (AML) - called NPM1 - that could help predict ...
Acute myeloid leukemia (AML) is a cancer of the bone marrow and blood. It is also called acute myelogenous leukemia or acute myelocytic leukemia. It happens when some of your blood stem cells stop ...
Scientists at St. Jude Children's Research Hospital are reporting the most comprehensive study to date describing the variations in drug response across different genetic subtypes of acute ...
Removing a protein that is often overexpressed in a rare and aggressive subtype of leukemia can help to slow the cancer's development and significantly increase the likelihood of survival, according ...
Researchers at Dana-Farber Cancer Institute have developed a diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- and AI-guided ...
After informed consent, we collected 25 samples from 24 patients: 15 CMMLs (8 MD-CMMLs and 7 MP-CMMLs), 2 acute transformations of CMML (AT-CMML), 5 MDSs (1 RARS (refractory anemia with ring ...
Non-Hodgkin’s lymphoma is a common type of blood cancer with several subtypes that require different treatments and have different outlooks. Non-Hodgkin’s lymphoma (NHL), sometimes just called ...
Researchers have identified a possible new targeted drug for treating acute myeloid leukemia. In the future, the discovery may help patients with certain rare subtypes of the disease. Targeted drugs ...
Vyxeos (CPX-351) was granted FDA approval for two subtypes of acute myeloid leukemia. Vyxeos (CPX-351), a fixed-combination of daunorubicin and cytarabine, was granted FDA approval for the treatment ...
Leukemia is the most common type of childhood cancer. In the U.S., an average of 3,718 children were diagnosed with leukemia every year from 2012-2016. Thankfully, the survival rates for childhood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results